Clinical Trial Update: Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the efficacy and safety of CD07805/47 topical gel for facial erythema in rosacea completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rosacea

Drugs mentioned

• CD07805/47 Topical Gel (CD07805/47 topical gel)

Snippet

Sponsor: Galderma R&D | Conditions: Rosacea | Phase 2 | Status: COMPLETED | Results posted: 2014-03-11